Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Gene Ther ; 15(16): 1167-75, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18432275

ABSTRACT

Gene transfer for cystic fibrosis (CF) airway disease has been hampered by the lung's innate refractivity to pathogen infection. We hypothesized that early intervention with an integrating gene transfer vector capable of transducing the lung via the lumen may be a successful therapeutic approach. An HIV-based lentiviral vector pseudotyped with the baculovirus gp64 envelope was applied to the fetal, neonatal or adult airways. Fetal intra-amniotic administration resulted in transduction of approximately 14% of airway epithelial cells, including both ciliated and non-ciliated epithelia of the upper, mid and lower airways; there was negligible alveolar or nasal transduction. Following neonatal intra-nasal administration we observed significant transduction of the airway epithelium (approximately 11%), although mainly in the distal lung, and substantial alveolar transduction. This expression was still detectable at 1 year after application. In the adult, the majority of transduction was restricted to the alveoli. In contrast, vesicular stomatitis virus glycoprotein pseudotyped virus transduced only alveoli after adult and neonatal application and no transduction was observed after fetal administration. Repeat administration did not increase transduction levels of the conducting airway epithelia. These data demonstrate that application at early developmental stages in conjunction with an appropriately pseudotyped virus provides efficient, high-level transgene expression in the murine lung. This may provide a modality for treatment for lung disease in CF.


Subject(s)
Baculoviridae/genetics , Genetic Therapy/methods , Genetic Vectors/administration & dosage , HIV/genetics , Transduction, Genetic/methods , Viral Envelope Proteins/genetics , Animals , Animals, Newborn , Cystic Fibrosis/metabolism , Cystic Fibrosis/therapy , Female , Gene Expression , Genetic Vectors/genetics , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Immunohistochemistry , Luciferases/analysis , Luciferases/genetics , Lung/growth & development , Lung/metabolism , Male , Mice , Mice, Inbred Strains , Models, Animal , Time , Transgenes
2.
Exp Cell Res ; 302(1): 69-82, 2005 Jan 01.
Article in English | MEDLINE | ID: mdl-15541727

ABSTRACT

Abnormalities in the control and execution of apoptosis are seen in many malignancies, including ovarian carcinoma. Many of these abnormalities involve the mitochondrial pathway of apoptosis, including overexpression of BIR-containing inhibitor of apoptosis protein (IAP) family proteins as well as dysregulated apoptosome function. We sought to stimulate the mitochondrial pathway of apoptosis by constructing a recombinant adenovirus encoding mature, processed Smac/DIABLO (Ad CMV tSmac), the second mitochondrial activator of caspases. Transfection of ovarian carcinoma cells with Ad CMV tSmac leads to increasing apoptosis in a dose-dependent manner. By contrast, transfection of IOSE397 immortalized normal ovarian surface epithelial cells does not cause apoptosis. We also show that the processed form of Smac is primarily expressed in the cytosol of ovarian carcinoma cells. Smac co-immunoprecipitates with both survivin and XIAP and stimulates survivin, but not XIAP, down-regulation. This down-regulation does not result from transcriptional changes, as determined by quantitative real-time PCR, but cycloheximide treatment indicates that survivin half-life is reduced from 6 to 2 h, which is secondary to ubiquitination and proteasomal degradation. RNA interference, however, suggests that survivin does not act to inhibit Smac-mediated apoptosis, which is confirmed by cotransfection with the phosphorylation mutant, survivin T34A. Finally, intraperitoneal delivery of Ad CMV tSmac increases median survival of mice bearing human ovarian carcinoma xenografts. We believe that expression of Smac/DIABLO can stimulate the intrinsic pathway of apoptosis in ovarian carcinoma without damaging normal ovarian tissue and therefore has therapeutic potential.


Subject(s)
Apoptosis/genetics , Carcinoma/metabolism , Carrier Proteins/metabolism , Microtubule-Associated Proteins/metabolism , Mitochondrial Proteins/metabolism , Ovarian Neoplasms/metabolism , Apoptosis Regulatory Proteins , Carcinoma/genetics , Carcinoma/therapy , Carrier Proteins/genetics , Carrier Proteins/pharmacology , Caspases/metabolism , Cell Line, Tumor , Dose-Response Relationship, Drug , Down-Regulation/genetics , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Female , Genetic Therapy/methods , Genetic Vectors/genetics , Genetic Vectors/pharmacology , Humans , Inhibitor of Apoptosis Proteins , Injections, Intraperitoneal , Intracellular Signaling Peptides and Proteins , Microtubule-Associated Proteins/genetics , Mitochondria/genetics , Mitochondria/metabolism , Mitochondrial Proteins/genetics , Mitochondrial Proteins/pharmacology , Neoplasm Proteins , Ovarian Neoplasms/genetics , Ovarian Neoplasms/therapy , Proteasome Endopeptidase Complex/genetics , Protein Synthesis Inhibitors/pharmacology , Proteins/metabolism , Survival Rate , Survivin , Up-Regulation/genetics , X-Linked Inhibitor of Apoptosis Protein
3.
Gene Ther ; 7(8): 644-52, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10800087

ABSTRACT

We have investigated the use of polycations to increase adenovirus-mediated expression of transgenic protein to the biliary epithelia with a view to gene therapy for hepatobiliary disease in CF. We have shown that adenovirus carrying the beta-galactosidase transgene transfect both human and mouse biliary epithelia in primary culture and that in both instances adenovirus transfection can be significantly increased by co-complexing with polycation. In vivo administration of 1 x 109 p.f.u. adenovirus co-complexed with the polyamine polyethyenimine (PEI) into the mouse biliary duct leads to >80% positively stained biliary epithelia while adenovirus alone at the same titre infected <5% biliary epithelia. We suggest that the use of low titre polycation enhanced adenoviral delivery to the biliary tree of CF patients could be of therapeutic significance. As a prelude to an extensive in vivo functional investigation in CF null mice we have shown that Ad5/polycation complexes deliver functional CFTR to non-CFTR expressing cells in vitro more efficiently than Ad5 alone.


Subject(s)
Adenoviridae/genetics , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Cystic Fibrosis/therapy , Genetic Therapy/methods , Genetic Vectors/administration & dosage , Transfection/methods , Animals , Cations , Cell Line , Culture Techniques , Epithelium , Gallbladder , Humans , Mice
4.
Genomics ; 16(2): 455-60, 1993 May.
Article in English | MEDLINE | ID: mdl-8314582

ABSTRACT

Batten disease, juvenile onset neuronal ceroid lipofuscinosis, is an autosomal recessive neurodegenerative disorder characterized by accumulation of autofluorescent lipopigment in neurons and other cell types. The disease locus (CLN3) has previously been assigned to chromosome 16p. The genetic localization of CLN3 has been refined by analyzing 70 families using a high-resolution map of 15 marker loci encompassing the CLN3 region on 16p. Crossovers in three maternal meioses allowed localization of CLN3 to the interval between D16S297 and D16S57. Within that interval alleles at three highly polymorphic dinucleotide repeat loci (D16S288, D16S298, D16S299) were found to be in strong linkage disequilibrium with CLN3. Analysis of haplotypes suggests that a majority of CLN3 chromosomes have arisen from a single founder mutation.


Subject(s)
Chromosomes, Human, Pair 16 , DNA, Satellite/genetics , Haplotypes/genetics , Neuronal Ceroid-Lipofuscinoses/genetics , Alleles , Base Sequence , Chromosome Mapping , Genes, Recessive , Genetic Markers , Humans , Lod Score , Molecular Sequence Data , Polymorphism, Genetic , Repetitive Sequences, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...